Clinical Analysis on Changes of Nitric Oxide(no),endothelin(et),thromboxane A2 and Prostaglandin I2 in Type 2 Diabetic Nephropathy

WANG Dong,CHEN Xia,LI Lian-xi,YANG Ling
DOI: https://doi.org/10.3969/j.issn.1671-7783.2006.06.015
2006-01-01
Abstract:Objective:To investigate the effects of nitric oxide(NO),endothelin(ET),thromboxane A_2(TXA_2) and prostaglandin I_2(PGI_2) in the occurrence and development of diabetic nephropathy(DN).Methods: Plasma NO,ET,TXB_2 and 6-keto-prostaglandin F_1α(6-keto-PGF1α) of 74 cases of type 2 diabetes mellitus(35males and 39 females),including 36 cases DN(19males and 17 females) and 26 healthy controls(14 males and 12 females) were measured. Results: NO and 6-keto-PGF1αlevels in type 2 DM were lower than those in control(P0.05).ET and TXB2 levels in type 2 DM were higher than those in control(P0.05).NO level in type 2 DN was lower than that in type 2 DM(P0.05).ET and urinary albumin excretion rate(UAER) levels in type 2 DN were higher than those in type 2 DM(P0.05). Conclusion: The disorders of NO and ET,TXA_2 and PGI_2 may play an important role in the occurrence and development of type 2 DN.
What problem does this paper attempt to address?